Ellington Management Group’s Novo Nordisk NVO Stock Holding History

Ellington Management Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21,200	Closed	-$548K	–	689
2019 Q3	$548K	Buy	+21,200	New	+$536K	0.1%	212
2017 Q4	–	Sell	-9,200	Closed	-$221K	–	746
2017 Q3	$221K	Buy	+9,200	New	+$208K	0.04%	493
2017 Q1	–	Sell	-70,200	Closed	-$1.26M	–	826
2016 Q4	$1.26M	Buy	70,200 +49,000	+231%	+$888K	0.19%	40
2016 Q3	$441K	Buy	+21,200	New	+$526K	0.12%	318
2013 Q4	–	Sell	-89,000	Closed	-$1.51M	–	729
2013 Q3	$1.51M	Sell	89,000 -134,000	-60%	-$2.25M	0.29%	56
2013 Q2	$3.46M	Buy	+223,000	New	+$3.71M	0.66%	13

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Ellington Management Group's NVO Position: Q4 2019 in Review

Ellington Management Group sold out of Novo Nordisk (NVO) in Q4 2019, closing a stake of 21,200 shares — an estimated $548K sold.

Ellington Management Group first reported a position in NVO in Q2 2013 and held it in 6 quarters. The position peaked at $3.46M in Q2 2013. 640 funds tracked by Wall St. Rank hold NVO as of Q4 2019.

Ellington Management Group reported no remaining Novo Nordisk position as of Q4 2019 after selling out during the quarter.
Ellington Management Group sold 21,200 Novo Nordisk shares in Q4 2019, an estimated $548K.
Ellington Management Group first reported a position in Novo Nordisk in Q2 2013 and held it in 6 quarters.
Ellington Management Group's Novo Nordisk position peaked at $3.46M in Q2 2013.
640 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2019.

Based on Ellington Management Group's 13F filing for Q4 2019, filed 14 Feb 2020.